← All indications
Abdominal Pain
Sensation of discomfort, distress, or agony in the abdominal region.
Subtype terms (1)
More specific conditions that are subtypes of Abdominal Pain in the MeSH hierarchy.
- Abdomen, Acute
12 drugs approved
Drugs by status
Approved for this indication (5)
Phase 4 trials (21)
Phase 3 trials (23)
- methylprednisolone
- ketamine
- citalopram
- doripenem
- secretin human
- ketorolac
- octreotide
- acetaminophen
- rifaximin
- levobupivacaine
- tannic acid
- tramadol
- bifidobacterium infantis
- bifidobacterium bifidum
- bifidobacterium longum
- azithromycin
- meropenem
- peppermint extract
- desipramine
- difelikefalin
- etoricoxib
- Lactobacillus acidophilus
- lactobacillus delbrueckii
Phase 2 trials (12)
Phase 1 trials (7)
Other trials (31)
- vitamin d3
- albendazole
- bifidobacterium animalis
- carbon dioxide
- capsaicin
- chamomile
- lactulose
- itropride
- ivermectin
- nystatin
- tinidazole
- cow milk
- sincalide
- autologous microbiome
- lactoflorene colesterolo
- pepsin
- perilla extract
- yili chang qing pro-abb
- zinc dichloride
- domperidone
- chickpea
- cellulase
- bacillus coagulans
- protein hydrolysates
- psyllium
- hyoscyamine
- id-jpl934
- water
- s-adenosyl methionine
- pancreatin
- +1 more
Organizations
Organization Involved with Phase 4 Indications (21)
- AstraZeneca
- Pfizer
- BioGaia AB
- Akdeniz University
- Cairo University
- Henry Ford Health System
- Medical University of Warsaw
- Northwestern University
- OhioHealth
- Thomas Jefferson University
- University of Milan
- University of Bologna
- University of Copenhagen
- University of Naples Frederico II
- Sprim Consulting
- Hennepin Healthcare
- Universidad Autonoma de Barcelona
- American College of Gastroenterology
- Yeshiva University
- University of Helsinki
- Ankara Yildirim Beyazıt University
Organization Involved with Phase 3 Indications (31)
- Novartis
- Boehringer Ingelheim
- ChiRhoClin, Inc.
- ZonMw: The Netherlands Organisation for Health Research and Development
- National Center for Research Resources (NCRR)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- National Institute of Mental Health (NIMH)
- Aarhus University
- Maastricht University
- Hospital Infantil Cândido Fontoura
- Ohio State University
- Sisters of Mercy University Hospital
- Tanta University
- University of Maryland
- University of Pavia
- University of Science Malaysia
- University of Southern Denmark
- University of Toronto
- Mayo Clinic
- Aalborg University
- Chinese University of Hong Kong
- Laval University
- University of Trieste
- Orlando Health
- Orebro University
- University of North Carolina at Chapel Hill
- Vita-Salute University of Milano. Italy
- Sao Paulo State University
- University of Western Ontario
- Morinaga Milk Industry Co. Ltd., Japan
- +1 more
Organization Involved with Phase 2 Indications (15)
Organization Involved with Phase 1 Indications (7)
Organization Involved with Other Experimental Indications (34)
- Amino Up Chemicals Co., Ltd.
- Danisco
- Inner Mongolia Yili Industrial Group Co., Ltd
- Montefarmaco OTC SpA
- National Center for Complementary and Integrative Health (NCCIH)
- United States Army
- University of Arizona
- Harvard University
- Mahidol University
- NHS Fife
- Seoul National University
- University of Southern California
- University of Athens
- University of Bari
- Aga Khan University
- Tel Aviv University
- University of Calgary
- University of California, San Diego
- Jiao Tong University
- BioTeSys GmbH
- University of Ljubljana
- Government of Pakistan
- Technion University
- Warsaw University
- University of Texas at Houston
- MRA Clinical Research
- Ben Gurion University
- Ganeden Biotech, Inc.
- Clinica Pediatrica Ospedale San Paolo
- Civil Hospital, Hyderabad, Pakistan
- +4 more